← SynDRA
TRABODENOSON
SynDRA canonical compound SYN0038296 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ADORA1 |
|---|
| Mechanism of action | adenosine receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- ADORA1 AGONIST
- Adenosine A1 receptor agonist
- adenosine receptor agonist
Cross-references
Synonyms
- Ino-8875
- INNO-8875
- PJ-875
- INO-8875
- Adenosine A1 agonist (atrial fibrillation), Inotek
- Adenosine A1 agonist (glaucoma), Inotek
- INNO 8875
- N-Cyclopentyladenosine 5'-nitrate
- N6-Cyclopentyladenosine 5'-nitrate
- 1T237110W4
- PJ 875
- trabodenosonum
- RefChem:933236
- DTXCID40158630
- Trabodenoson [USAN:INN]
- UNII-1T237110W4
- MFCD28502082
- Trabodenoson [INN]
- C15H20N6O6
- Trabodenoson (USAN/INN)
- TRABODENOSON [USAN]
- SCHEMBL121828
- orb1695021
- SCHEMBL29359454
- BDBM97464
- N-Cyclopentyladenosine 5 -nitrate
- BDBM108255
- GLXC-15845
- N-Cyclopentyl-5'-O-nitroadenosine
- AKOS027337131
- AKOS040754236
- AS-52370
- US8470800, A
- HY-106007
- CS-0024616
- NS00072168
- D10493
- P14975
- T34914
Look up TRABODENOSON in the interactive SynDRA portal →